fda removes tirzepatide from shortage list As of February 21, 2025, the updated its drug list, marking the semaglutide injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A fda removes tirzepatide Zepbound Shortage

Fontes-Dutra M, Santos-Terra J, Deckmann I, Brum Schwingel G, Della-Flora Nunes G, Hirsch MM, Bauer-Negrini G, Riesgo RS, Bambini-Jnior V, Hedin-Pereira C, Gottfried C

If, for any reason, there are challenges with insurance coverage, there are other alternative payment options and assistance programs that you can explore to make Semaglutide GLP-1 injections more affordable

citizen meds have been great to work with and I love that they add B12 to their compounded formula

What do these terms mean

COVERAGE OUTLOOK What's Changing in 2026 2026: Diverging Trends The insurance landscape for Zepbound is splitting: Medicare/Medicaid expanding via new CMS pilot programs while many commercial plans are pulling back